| Item Type | Name |
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Hirudin Therapy
|
|
Concept
|
Thrombolytic Therapy
|
|
Academic Article
|
The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
|
|
Academic Article
|
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
|
|
Academic Article
|
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
|
|
Academic Article
|
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
|
|
Academic Article
|
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
|
|
Academic Article
|
Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).
|
|
Academic Article
|
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
|
|
Academic Article
|
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
|
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
|
|
Academic Article
|
Apixaban for extended treatment of venous thromboembolism.
|
|
Academic Article
|
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
|
|
Academic Article
|
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.
|
|
Academic Article
|
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
|
|
Academic Article
|
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
|
|
Academic Article
|
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
|
|
Academic Article
|
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
|
|
Academic Article
|
Anticoagulant therapy for venous thromboembolism.
|
|
Academic Article
|
Hemorrhagic complications of long-term anticoagulant therapy.
|
|
Academic Article
|
Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
|
|
Academic Article
|
Preventing systemic embolism in patients with abnormal ventricular function.
|
|
Academic Article
|
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
|
|
Academic Article
|
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
|
|
Academic Article
|
Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
|
|
Academic Article
|
Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
|
|
Academic Article
|
Treatment of venous thromboembolism.
|
|
Academic Article
|
Oral anticoagulant therapy.
|
|
Academic Article
|
Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice.
|
|
Academic Article
|
Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.
|
|
Academic Article
|
The evidence-based analysis of treatment for chronic myeloid leukemia: An introduction to its methods and clinical implications.
|
|
Academic Article
|
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
|
|
Academic Article
|
Idraparinux versus standard therapy for venous thromboembolic disease.
|
|
Academic Article
|
Extended prophylaxis of venous thromboembolism with idraparinux.
|
|
Academic Article
|
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
|
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
|
|
Academic Article
|
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
|
|
Academic Article
|
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
|
|
Academic Article
|
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
|
|
Academic Article
|
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
|
|
Academic Article
|
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
|
|
Academic Article
|
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
|
|
Academic Article
|
New paradigms in venous thromboprophylaxis of medically ill patients.
|
|
Academic Article
|
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
|
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
|
|
Academic Article
|
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
|
|
Academic Article
|
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
|
|
Academic Article
|
Heparin therapy for venous thrombosis and pulmonary embolism.
|
|
Academic Article
|
A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis.
|
|
Academic Article
|
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
|
|
Academic Article
|
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
|
Academic Article
|
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
|
|
Academic Article
|
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
|
Academic Article
|
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
|
|
Academic Article
|
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
|
Academic Article
|
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
|
Academic Article
|
Prevention of central venous catheter-associated thrombosis: a meta-analysis.
|
|
Academic Article
|
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
|
|
Academic Article
|
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
|
|
Academic Article
|
Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
|
|
Academic Article
|
Hemorrhagic complications of long-term anticoagulant therapy.
|
|
Academic Article
|
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
|
|
Academic Article
|
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
|
|
Academic Article
|
Oral apixaban for the treatment of acute venous thromboembolism.
|
|
Academic Article
|
Long-term anticoagulant therapy prevents recurrent venous thromboembolism.
|
|
Academic Article
|
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
|
|
Academic Article
|
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
|
|
Academic Article
|
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
|
|
Academic Article
|
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
|
|
Academic Article
|
A noninvasive strategy for the treatment of patients with suspected pulmonary embolism.
|
|
Academic Article
|
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
|
|
Academic Article
|
Hirudin versus heparin and low-molecular-weight heparin: and the winner is...
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement.
|
|
Academic Article
|
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
|
|
Academic Article
|
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
|
|
Academic Article
|
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
|
|
Academic Article
|
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
|
|
Academic Article
|
Prevention and treatment of venous thromboembolism--International Consensus Statement.
|
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
|
|
Academic Article
|
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
|
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
|
|
Academic Article
|
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
|
|
Academic Article
|
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
|
|
Academic Article
|
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
|
|
Academic Article
|
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
|
|
Academic Article
|
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
|
|
Academic Article
|
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
|
|
Academic Article
|
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
|
|
Academic Article
|
Prophylaxis of venous thromboembolic disease following hip and knee surgery.
|
|
Academic Article
|
Prophylaxis of venous thromboembolism. An overview.
|
|
Academic Article
|
Risk of haemorrhage associated with long term anticoagulant therapy.
|
|
Academic Article
|
Methodological guidelines for clinical trials evaluating new therapeutic approaches in bone and joint surgery.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
Long-term oral anticoagulant therapy for coronary artery disease.
|
|
Academic Article
|
Duration of anticoagulant treatment for venous thrombosis.
|
|
Grant
|
THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
|
|
Academic Article
|
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
|
|
Academic Article
|
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
|
|
Academic Article
|
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
|
|
Academic Article
|
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
|